Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ventricular Dysfunction, Left

• A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfun
• Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
• Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
• Corticoid Therapy in Acute Myocarditis
• Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
• Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
• Pharmacokinetics of Inhaled Levosimendan
• DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
• Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
• Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
• Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
• Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction
• The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
• Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
• Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
• Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
• Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
• Performance and Safety of the Cardiac Microcurrent Therapy System
• Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
• Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
• Ivabradine in Cirrhotic Cardiomyopathy
• Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
• The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
• Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
• A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
• A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
• Preoperative levosimendán and Hip Fracture
• Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2
• Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
• Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
• Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
• Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
• NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
• High-dose Selenium Supplementation in Patients With Left Ventricular Assist
• The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
• A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction
• Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
• Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
• Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
• Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
• The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
• STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
• Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
• Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
• Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
• Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
• Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
• Heart Rate Response to Regadenoson and Sudden Cardiac Death
• Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure
• Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
• Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
• COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
• Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
• Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
• Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
• Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
• Prevention of Left Ventricular Dysfunction During Chemotherapy
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
• Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
• Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
• Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol
• The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
• Effects of Viagra on Heart Function in Patients With Heart Failure
• Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
• Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function
• Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
• Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
• Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
• Insulin Cardioplegia for Poor Left Ventricular Function
• The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
• Studies of Left Ventricular Dysfunction (SOLVD)